SCHEMBL3267426

SCHEMBL3267426

O=CC1=C(Br)c2cc(Cl)ccc2CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.42
PARP1 P09874 1/20 0.42
F3 P13726 1/20 0.42
PARP10 Q53GL7 1/20 0.42
TYMS P04818 2/20 0.37
TDP1 Q9NUW8 2/20 0.35
SRD5A1 P18405 2/20 0.35
SRD5A2 P31213 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
CYP19A1 P11511 2/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
S100A4 P26447 1/20 0.33
METAP1 P53582 1/20 0.33
ERN1 O75460 1/20 0.33
HTT P42858 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30856007 1.00 F7 (0.42) F7PARP1F3PARP10TYMS
SCHEMBL30855798 0.87 SRD5A1 (0.45) TYMSTDP1SRD5A1SRD5A2ALDH1A1
SCHEMBL30856147 0.83 TDP1 (0.49) PARP1PARP10TYMSTDP1SRD5A1
SCHEMBL31620343 0.80 PARP1 (0.42) PARP1PARP10TYMSTDP1SRD5A1
SCHEMBL12522126 0.80 TYMS (0.43) F7PARP1F3PARP10TYMS
SCHEMBL3267757 0.80 PARP1 (0.42) PARP1PARP10TYMSTDP1SRD5A1
SCHEMBL3268773 0.78 F7 (0.44) F7PARP1F3PARP10TYMS
SCHEMBL29615759 0.75 CES1 (0.47) PARP1PARP10TDP1SRD5A1SRD5A2
SCHEMBL4268656 0.75 CES1 (0.47) PARP1PARP10TDP1SRD5A1SRD5A2
SCHEMBL29951071 0.73 PARP10 (0.46) F7PARP1F3PARP10TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
CN-101300244-A Novel cercosporamide derivative DAIICHI SANKYO CO LTD (JP) 2008-11-05 CN disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 F7 3317/4885PARP1 4384/4885F3 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.